Edan Instruments, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
April 26, 2023 at 03:59 am EDT
Share
Edan Instruments, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 639.69 million compared to CNY 389.56 million a year ago. Revenue was CNY 639.69 million compared to CNY 389.56 million a year ago.
Net income was CNY 140.42 million compared to CNY 49.55 million a year ago. Basic earnings per share from continuing operations was CNY 0.2423 compared to CNY 0.0852 a year ago. Diluted earnings per share from continuing operations was CNY 0.2423 compared to CNY 0.0852 a year ago.
Edan Instruments, Inc. is a China-based company principally engaged in the research, development, manufacture, sales of medical electronic equipment products and in-vitro diagnostic products, as well as the provision of related services. The Company provides maternity product series, including doppler fetal heart beat monitors, ultrasonic doppler fetal heart beat monitors, fetal/maternal monitors and maternity integrated diagnostic monitoring systems; electrocardiograph series, including digital twelve-channel electrocardiographs, digital six-channel electrocardiographs, electrocardiographic workstations, single-channel electrocardiographs and multi-channel electrocardiographs; monitoring product series, including portable multi-variable monitors, central monitoring systems and oximeters, as well as ultrasonic image product series, including digital ultrasonic diagnostic systems and others. The Company is also involved in the spare parts sale and in vitro diagnostics products business.
EDAN INSTRUMENTS, INC. 
